tamoxifen and raloxifene for preventing breast cancer
July 1999
The Nat'l Cancer Institute is now starting a HUGE study to compare tamoxifen and raloxifene for preventing breast cancer.
It's called STAR..."Study of Tamoxifen And Raloxifene."
Tamoxifen (Nolvadex) reduces the risk of breast cancer by almost 50% in high-risk women.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote